相关实验视频

Updated: Jul 11, 2025

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

探索ADC组合对三阴性乳腺癌的治疗潜力

Linlin Lu¹, Zihe Niu², Zhujun Chao²

¹Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215000, China.

Cellular and molecular life sciences : CMLS

|November 6, 2023

概括

三重阴性乳腺癌 (TNBC) 的治疗方法有限. 抗体-药物合物 (ADC) 是有前途的,但耐药性很常见,这表明组合疗法是改善TNBC结果的关键.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
生物技术是生物技术.

背景情况:

三阴性乳腺癌 (TNBC) 是一种具有有限治疗选择和高复发率的侵袭性亚型.
像手术,化疗和放射治疗这样的标准疗法存在重大局限性.
抗体-药物合物 (ADCs) 是一种用于癌症治疗的新型治疗类.

研究的目的:

审查抗体-药物合物 (ADC) 在治疗三阴性乳腺癌 (TNBC) 的当前应用.
探索ADC组合疗法的潜力,以克服TNBC中治疗耐药性的可能性.
讨论ADC在TNBC管理中的未来前景.

主要方法:

目前的ADCs的文献综述,包括sacituzumab govitecan.
对TNBC中ADC疗效和耐药机制的临床研究的分析.
探索支持使用ADC的组合策略的证据.

主要成果:

ADCs,如sacituzumab govitecan,已获得批准,并正在为TNBC进行调查.
患者的有限反应和获得的耐药性是当前ADC治疗的重大挑战.
组合疗法正在成为提高ADC有效性的策略.

结论:

ADCs为TNBC提供了一个有前途的治疗途径.
通过组合策略克服耐药性对于改善患者的治疗结果至关重要.
对ADC组合疗法的进一步研究是有效的TNBC治疗的必要条件.

关键词:

抗体药物联结物抗体药物联结物组合治疗组合治疗美国TNBC电视台

更多相关视频

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on: August 18, 2023

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...